Studies have shown that dexamisson can save the lives of patients with severe neo-pneumonia
-
Last Update: 2020-11-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Local time, WHO said on the 16th, the United Kingdom's preliminary clinical trial results show that dexamisong can save the lives of patients with severe neo-coronary pneumonia, for patients using ventilators, can reduce their mortality rate by about a third, for oxygen-only patients, can reduce their mortality rate by about one-fifth. The study noted that the improvement effect of dexamisund was only visible in severe patients and not in patients with mild illness.
WHO Director-General Tan Desser said it was the first treatment to reduce mortality in patients with new coronary pneumonia who needed oxygen or used a ventilator, which was good news and congratulated the UK government, Oxford University and hospitals and patients who had contributed to the breakthrough.
is a steroid that has been used since the 1960s to reduce inflammation of a variety of diseases. Since 1977, it has been included in the World Health Organization's Standard List of Essential Medicines in a variety of preparations. (Chief Station Reporter Zhu He)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
